HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CFSAN priorities

This article was originally published in The Rose Sheet

Executive Summary

FDA requests public comment on the Center for Safety & Applied Nutrition's program priorities for 2000 in an announcement published in the Federal Register Sept. 1. Comments are due Sept. 30. CFSAN's 1999 "A" priority list includes reinstating the Voluntary Cosmetic Registration Program and completing the safety assessment and review of alpha hydroxy acids and diethanolamine (1"The Rose Sheet" Feb. 1, p. 7). Among goals on the Office of Cosmetics & Colors' priority "B" list in 1999 is issuing a report on adverse reactions (2"The Rose Sheet" Feb. 8, p. 6)
Advertisement

Related Content

CTFA
CTFA
FDA "B" List For Cosmetics Priorities Includes Adverse Event Monitoring
CFSAN Priorities List For 1999 Includes Four Cosmetics Issues
CFSAN Priorities List For 1999 Includes Four Cosmetics Issues
Advertisement
UsernamePublicRestriction

Register

RS007086

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel